Since the widespread use of core needle biopsies (CNBs) for diagnosing breast lesions, fine-needle aspiration (FNA) biopsy is dramatically decreasing. Contributing factors to the decrease in FNA of breast masses include FNA's inability to separate atypical ductal hyperplasia (ADH) from ductal carcinoma in situ (DCIS) and DCIS from the invasive carcinoma, which has patient management implications. However, CNB also has some inherent limitations due to its occasional inability to make a definitive diagnosis for a number of breast lesions and discordance between ancillary studies performed on CNB versus the resected specimen results. CNB has now become the standard of care in the United States for evaluation of nonpalpable breast lesions. For palpable lesions, FNA appears currently to have the most value as completing the "triple test" for a negative diagnosis and confirming the diagnosis of locally advanced and/or inoperable carcinoma, locally recurrent breast cancer, and metastatic disease. FNA in the hands of experienced cytologists still has an important role in the diagnosis of primary palpable breast cancers. Familiarity and understanding the advantages and limitations of each biopsy technique will help select the most appropriate procedure for the workup of the patient with a breast mass.
CASE REPORTSCase 1 F ine-needle aspiration (FNA) and ultrasound-guided core needle biopsies (CNBs) of a right periareolar breast lesion in a 61-year-old presenting with multiple bone lesions and spinal cord compression were performed. The clinical differential diagnosis was multiple myeloma versus metastatic carcinoma. FNA cytologic examination revealed the presence of loose clusters and individually scattered, mildly atypical cells demonstrating slight nuclear enlargement and irregularity, consistent with possible lobular carcinoma due to the uniform, mildly atypical features and the relatively small size of the atypical cells (Fig. 1). However, final classification needed to await examination of the CNB. The concomitant CNB demonstrated an invasive lobular carcinoma, nuclear grade 2. The malignant cells were immunohistochemically positive for estrogen receptor protein and progesterone receptor protein and negative for HER-2/neu.
Case 2A 41-year-old woman underwent a FNA and CNB of 2 left breast lesions measuring 2.8 and 1.3 cm in maximum dimension, respectively. The FNA cytology was interpreted as ductal carcinoma, and the CNB demonstrated an invasive ductal carcinoma, mucinous/colloid type, nuclear grade 3, with angiolymphatic invasion (Fig. 2). The malignant cells in the CNB were positive for estrogen and progesterone receptor protein with borderline 2ϩ positive HER-2/neu.
DISCUSSIONCases 1 and 2 demonstrate some of the limitations of FNA biopsy that have resulted in the greater use of CNB for diagnosing breast lesions and the concomitant decreasing utilization of FNA biopsy. 1-4 However, we still believe that FNA biopsy has a role in the workup of breast lesions since FNA cytology can quickly and accurately separate ben...